PureTech Health PLC Director Declaration (0398G)

TIDMPRTC

RNS Number : 0398G

PureTech Health PLC

10 November 2022

PureTech Health plc

Director Declaration

Pursuant to Listing Rule 9.6.14(2), PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") notes that Christopher Viehbacher, a Non-Executive Director and Chair of the Company's Board, has been appointed as President and Chief Executive Officer and a member of the Board of Biogen Inc. (Nasdaq: BIIB) with effect from November 14, 2022.

For further information please contact:

Bharatt Chowrira, PhD, JD, President and Chief Business, Finance and Operating Officer, member of the Board of Directors and Company Secretary: +1 617 482 2333

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNEAKFEFFPAFFA

(END) Dow Jones Newswires

November 10, 2022 12:00 ET (17:00 GMT)

Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024